Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BGM Group Ltd. (BGM) vs InterCure Ltd. (INCR)

BGM Group Ltd. and InterCure Ltd. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. is the larger, with a market value of $104.6M against $62.3M — 1.7× the size. BGM Group Ltd. trades at the lower P/E: 4.0× against 9.8×. InterCure Ltd. has the higher net margin (4.88% vs 1.96%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, InterCure Ltd. leads on 6 and BGM Group Ltd. on 5.

Valuation

Metric BGM INCR Drug Manufacturers Specialty & Generic median
P/E 4.00 9.84 20.14
P/S n/m 1.98 2.25
P/B n/m 1.96 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 23.47 12.29
EV/Sales (0.09) 2.12 2.56
Earnings yield 25.00% 10.16% (2.99%)
Free cash flow yield 0.00% (0.34%) 0.00%

Profitability

Metric BGM INCR Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 32.74% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 1.96% 4.88% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.40%)
Return on assets 0.00% 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BGM INCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 16.15% 10.01%
EPS growth (last fiscal year) 10.00% 52.50% —
Revenue growth, 5-year CAGR (5.39%) 31.11% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM INCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.27 0.05
Current ratio 1.25 1.85 2.31
Net debt to EBITDA 0.97 (4.07) 0.85

Dividend

Metric BGM INCR Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BGM INCR Drug Manufacturers Specialty & Generic median
Market cap 104.61m 62.33m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack